Cancer cells typically exhibit elevated reactive oxygen species (ROS) levels that are counterbalanced by upregulation of antioxidant systems, including TXN1/TXNRD1 and PDIs, which also act at the cell surface. This evidence concerns the gene TXN and cancer.